What is the current Price Target for the Passage Bio Inc stock?

The average Passage Bio Inc target price is $64.77. This is 771.74% higher than the current stock price. The highest price target is 1,595.83%, the lowest is 35.94%. 6 Analysts have issued a price target Passage Bio Inc 2026 .

How high will the Passage Bio Inc stock rise?

No reliable answer can be given as to how high the Passage Bio Inc stock will rise. The performance of stocks, including the Passage Bio Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Passage Bio Inc stock today?

The performance of Passage Bio Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Passage Bio Inc stock fall?

The decline in Passage Bio Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Passage Bio Inc Forecast, price target & analysts

$7.14

3.86% today

Nasdaq, Oct 24, 10:00 pm CET

ISIN

US7027121000

Symbol

PASG

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Passage Bio Inc Target price 2025 - Analyst rating & recommendation

Passage Bio Inc Classifications & Recommendation:

Buy

91%

Hold

Passage Bio Inc Price Target

Target Price	$64.77
Price	$7.43
Potential	771.74% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target Passage Bio Inc 2026 . The average Passage Bio Inc target price is $64.77. This is 771.74% register free of charge higher than the current stock price. The highest price target is $126.00 1,595.83% register free of charge , the lowest is $10.10 35.94% register free of charge .
	A rating was issued by 11 analysts: 10 Analysts recommend Passage Bio Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Passage Bio Inc stock has an average upside potential 2026 of 771.74% register free of charge . Most analysts recommend the Passage Bio Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-21.44	-12.29
	42.50%	42.68%
P/E		negative

7 Analysts have issued a Passage Bio Inc forecast for earnings per share. The average Passage Bio Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-21.44	42.50%
2025	$-12.29 42.68% Unlock
2026	$-6.02 51.02% Unlock
2027	$-4.21 30.07% Unlock
2028	$-0.36 91.45% Unlock
2029	$7.44 2,166.67% Unlock
2030	$16.27 118.68% Unlock
2031	$1.65 89.86% Unlock
2032	$1.50 9.09% Unlock

Current	-0.41	20.67%
2025	-0.60 44.86% Unlock
2026	-1.24 106.67% Unlock
2027	-1.76 41.94% Unlock
2028	-20.81 1,082.39% Unlock
2029	1.00 104.81% Unlock
2030	0.46 54.00% Unlock
2031	4.50 878.26% Unlock
2032	4.96 10.22% Unlock

Passage Bio Inc...

Current Passage Bio Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Canaccord Genuity	Locked ➜ Locked	Locked	Aug 14 2025
Guggenheim	Locked ➜ Locked	Locked	Aug 14 2025
Wedbush	Locked ➜ Locked	Locked	Aug 13 2025
Chardan Capital	Locked ➜ Locked	Locked	Jun 24 2025
Chardan Capital	Locked ➜ Locked	Locked	Mar 04 2025
Canaccord Genuity	Locked ➜ Locked	Locked	Nov 14 2024
Chardan Capital	Locked ➜ Locked	Locked	Nov 14 2024

Analyst Rating	Date
Locked Canaccord Genuity: Locked ➜ Locked	Aug 14 2025
Locked Guggenheim: Locked ➜ Locked	Aug 14 2025
Locked Wedbush: Locked ➜ Locked	Aug 13 2025
Locked Chardan Capital: Locked ➜ Locked	Jun 24 2025
Locked Chardan Capital: Locked ➜ Locked	Mar 04 2025
Locked Canaccord Genuity: Locked ➜ Locked	Nov 14 2024
Locked Chardan Capital: Locked ➜ Locked	Nov 14 2024

Discover more stocks with a high price target

TUI 50.73%

Deutsche Telekom 33.66%

BioNTech SE - ADR 33.40%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now